Metacrine, Inc. — Form D/A
Metacrine, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2016-11-09. The offering totals $37.8M, of which $37.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-11-09
- Form: D/A
- Accession: 0001634379-16-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $37.8M
- Amount sold: $37.8M
- Investors: 20
- Date of first sale: 2015-01-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-237785
Issuer
- Name: Metacrine, Inc.
- CIK: 0001634379
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3985 Sorrento Valley Blvd., San Diego, CA, 92121
- Phone: (858) 369-7800
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Trisha Millican | Executive Officer | South San Francisco, CA |
| Carol Gallagher | Director | Carlsbad, CA |
| Kristina Burow | Director | San Diego, CA |
| Ken Song | Director | San Diego, CA |
| Ken Song | Executive Officer | San Diego, CA |
| AMIR NASHAT | Director | San Diego, CA |
| Neil McDonnell | Director | Burnaby, A1 |
| Neil McDonnell | Executive Officer | Burnaby, A1 |
| Robert Adelman | Director | San Francisco, CA |
| Richard Heyman | Director | South San Francisco, CA |
| Ronald Evans | Director | Avon, CT |
| Patricia Millican | Executive Officer | San Diego, CA |
| Kenneth Song | Director | San Diego, CA |
| Kenneth Song | Executive Officer | San Diego, CA |
| Jackie Hernandez | Executive Officer | Larchmont, NY |
Other filings by this issuer (4)
More